Neuron-secreted chemokine-like Orion interacts with the glial receptor Draper during mushroom body neuronal remodeling in Drosophila

Across the animal kingdom, neuronal remodeling is a crucial developmental mechanism to refine neurite targeting necessary for both maturation and function of neural circuits. The neuronal chemokine-like Orion is essential for astrocyte infiltration and likely for phagocytosis during mushroom body γ-neuron remodeling during metamorphosis in Drosophila. The Drpr phagocytic receptor is a critical and well-studied regulator of many aspects of neuronal remodeling, where it is required for neurite pruning and cell body removal. In this study, we show a drpr^null allele displaying a mushroom body (MB)-pruning phenotype very similar, if not identical, to that of orion^null alleles. Furthermore, when Orion is permanently tethered to the surface of the γ-axons, we show strong genetic interactions between neuronal Orion and glial Drpr. These results strongly suggest that Drpr is the glial receptor for Orion in mushroom body neuronal remodeling.

Introduction

During nervous system development in both vertebrates and invertebrates, neurons undergo a remodeling process that is necessary for their normal function (Luo and O'Leary, 2005; Neukomm and Freeman, 2014; Schuldiner and Yaron, 2015). Moreover, it is suggested that excess or insufficient remodeling may underlie several neurodegenerative diseases (Cardozo et al., 2019; Courchesne et al., 2007). Glial cells play an essential role in both neuronal remodeling and neurodegenerative diseases. A critical crosstalk between glia and neurons is required in both processes; however, little is known about this intercellular cooperation (Boulanger and Dura, 2022; Neniskyte and Gross, 2017). Orion is a secreted chemokine-like protein, which has been described as a necessary component for neuronal remodeling in different paradigms in Drosophila (Boulanger et al., 2021; Ji et al., 2023; Perron et al., 2023). Orion is a ligand that should interact with its receptor to transform the surrounding glial or epidermal cells into phagocytes for neurite debris elimination. Therefore, the identification of the Orion receptor is of paramount importance to understand the phagocytic clearance of degenerating neurons. Importantly, in the case of the phagocytosis of degenerating dendrites of class IV dendritic arborization (C4da) neurons, it was shown that Orion bridges phosphatidylserine (PS), a conserved “eat-me signal,” and the phagocytic receptor Drpr (draper) (Ji et al., 2023). Drpr is involved in many aspects of neuronal remodeling and debris clearance during development or after injury in Drosophila (Boulanger and Dura, 2022; Freeman et al., 2003; Tasdemir-Yilmaz and Freeman, 2014). We aimed to assess whether Drpr can also be a receptor for Orion in the case of mushroom body (MB) neuronal remodeling. MBs are bilateral and symmetrical brain structures required for learning and memory. During metamorphosis, the MB-larval-specific dendrites and axons of early γ-neurons are pruned and replaced by adult-specific processes necessary for memory (Boulanger et al., 2011; Boulanger and Dura, 2015; Redt-Clouet et al., 2012; Trannoy et al., 2011; Yu and Schuldiner, 2014). We show here that the drpr^indel3 null allele has a MB-pruning phenotype very similar, if not identical, to that of orion^null alleles. Furthermore, by using an Orion-CD2 transgene in which Orion is permanently tethered to the surface of the MB axons, we show, first, a high recruitment of glial Drpr inside γ-axon bundles and, second, strong genetic interactions between Orion and glial Drpr. These results strongly suggest that Drpr is the glial receptor for Orion in MB neuronal remodeling.

Materials and methods

Drosophila stocks

All crosses were performed using standard culture medium at 25 °C. All fly strains were tested, either through Western blotting, immunostaining, PCR or phenotypically. orion^null mutants (orion¹ and orion^ΔC) were produced in a previous study in our laboratory (Boulanger et al., 2021). drpr^indel3, UAS-orionB-CD2-mIFP, and UAS-HO1 flies were a gift from Chun Han. drpr^Δ5 and UAS-drpr flies were a gift from Marc Freeman. Nimc1¹; eater¹ double-mutant flies were a gift from Bruno Lemaitre. UAS>y⁺ CD2>CD8-mGFP (called here UAS>y⁺>mGFP) flies were a gift from Reinhard Stocker and used here, as UAS-HO1, as a neutral UAS to equilibrate the numbers of UAS sequences between experiments and controls. UAS-orionB-CD2-myc contains the same sequence, for the Orion-CD2 part, as UAS-orionB-CD2-mIFP previously described (Ji et al., 2023), and was synthesized by GenScript. Cloning and transgenesis were performed as in previous UAS constructions (Boulanger et al., 2021). We used two GAL4 lines: 201Y-GAL4 expressed in MB γ-neurons and repo-GAL4 expressed in all glia.

Brain dissection and immunostaining

Adult drosophila heads were fixated in formaldehyde (FA) 3.6% in phosphate-buffered saline (PBS) for 1 hour before dissection in PBS 1×. Larva were directly dissected in PBS 1×, and brains were then fixated in FA 3.6% for 15 min. They were then treated for immunostaining, as previously described (Boulanger et al., 2021). Antibodies were used at the following dilutions: mouse monoclonal anti-Fas2 (1D4, DSHB) 1:10; mouse monoclonal anti-Dally-like protein (Dlp) (13G8, DSHB) 1:200; rabbit monoclonal anti-myc (71D10, Abcam) 1:500; and mouse monoclonal anti-Drpr (8A1, DSHB) 1:300. Goat secondary antibodies conjugated to Cy3 and Cy5 against mouse and rabbit IgG, respectively (Jackson ImmunoResearch), were used at 1:300 for detection. For Western blotting, antibodies were used at the following concentrations: mouse monoclonal anti-Drpr (8A1, DSHB) 1:500; mouse monoclonal anti-tubulin (T5168, Sigma-Aldrich) 1:10,000; peroxidase-conjugated AffiniPure Goat anti-mouse IgG 1:10000 (Jackson ImmunoResearch).

Western blotting

For protein extraction, 10 pupal brains (6 h APF) were mashed into 20 mL of Laemmli buffer 2× with β-mercaptoethanol for each condition and stored at −20 °C. Proteins were separated on a 10% agarose gel (Mini-PROTEAN TGX precast gels, Bio-Rad) and transferred to a PVDF membrane (Merck). The membrane was blocked in 5% milk before primary antibody addition overnight at 4 °C. After washing in PBS–Tween 0.1%, the membrane was incubated in milk 5% with the secondary antibody for an hour at room temperature and then washed again in PBS–Tween 0.1%. Detection was performed using ChemiDoc from Bio-Rad.

Microscopy

Images were acquired using a Leica SP8 laser scanning confocal microscope (MRI Platform, Institute of Human Genetics, Montpellier, France) equipped with a 40× PLAN apochromatic 1.3 oil-immersion differential interference contrast objective lens. The immersion oil used was Immersol 518F. The acquisition software used was Leica Application Suite X (LAS X).

Quantitation

For image quantitation of Orion-CD2 titration, MBs were analyzed using an epifluorescence microscope. They were blindly classified into two different groups based on the presence of the ''head'' of the MB dorsal γ-lobe (preserved) or absence of this head (headless). For Drpr titration, confocal images taken using the same confocal settings were used, and the surface of the dorsal γ-lobe was quantified using Fiji software. The dorsal lobe was first isolated; then, a threshold was manually set for each dorsal lobe, and the function ''Analyze particle'' generated the surface of fluorescence. To quantify the presence of Drpr in the mushroom body at larval stages, confocal images taken at the same confocal settings were analyzed on Imaris XT. A surface of the γ-lobe was created using the green fluorescence, allowing the generation of a second surface with the Drpr staining contained within it.

Statistics

Comparison between two groups expressing a qualitative variable was analyzed for statistical significance using the Fisher exact test. Comparison of two groups expressing a quantitative variable was analyzed using the two-sided nonparametric Mann–Whitney U test. Graphs were created using GraphPad Prism software (version 10.3.1). Statistical significance was defined as ****P < 0.0001; ***P < 0.001; **P < 0.01; *P < 0.05; ns, not significant. The sample size of each group (n) is included in a parenthesis in figures.

List of fly strains

Figure 1.

A. y w^67c23/y w^67c23; UAS-mCD8GFP 201Y-GAL4/+ or y w^67c23/Y; UAS-mCD8GFP 201Y-GAL4/+

B. y w^67c23 sn³ orion¹ FRT19A/Y; UAS-mCD8GFP 201Y-GAL4/+

C. y w^67c23/y w^67c23; UAS-mCD8GFP 201Y-GAL4/+; drpr^indel3/drpr^indel3 or y w^67c23/Y; UAS-mCD8GFP 201Y-GAL4/+; drpr^indel3/drpr^indel3

D–E. y w^67c23/y w^67c2; UAS-mCD8GFP 201Y-GAL4/+; drpr^Δ5/drpr^Δ5 or y w^67c23/Y; UAS-mCD8GFP 201Y-GAL4/+; drpr^Δ5/drpr^Δ5

F. w¹¹¹⁸ (Canton-S)

G. w^67c23 orion^ΔC/Y

H. y w^67c23/y w^67c23; +; drpr^indel3/drpr^indel3 or y w^67c23/Y; +; drpr^indel3/drpr^indel3

I–J. y w^67c23/y w^67c23; +; drpr^Δ5/drpr^Δ5 or y w^67c23/Y; +; drpr^Δ5/drpr^Δ5

K. w¹¹¹⁸; Nimc1¹; eater¹

L. y w^67c23/y w^67c23 or y w^67c23/Y

y w^67c23/y w^67c23; +; drpr^Δ5/drpr^Δ5 or y w^67c23/Y; +; drpr^Δ5/drpr^Δ5

y w^67c23/y w^67c23; +; drpr^indel3/drpr^indel3 or y w^67c23/Y; +; drpr^indel3/drpr^indel3

Figure 1

Figure 1. Drpr and Orion mutants exhibit a similar phenotype. (A–E) γ-neurons of 7-day adult flies were visualized via the expression of 201Y-GAL4-driven UAS-mCD8-GFP (green) and using the anti-Fas2 antibody (red). For unknown reasons, the GFP fluorescence in the 201Y-GAL4-GFP; drpr^indel3 strain appeared faint, except for the axonal debris that quickly reached saturation if increasing the signal. However, this effect is independent of the phenotype, which is clearly represented later in this figure with the anti-Dlp antibody. The 201Y-GAL4 line also labels the αβ-core axons shown here by asterisks. Note the presence of unpruned γ-axons (arrowhead) and the high amount of uncleared axonal debris (arrows) in orion¹, drpr^indel3, and drpr^Δ5 compared to the wild-type. drpr^indel3 MBs showed a lack of pruning with a complete penetrance (n = 36). All (100%) of these MBs showed both unpruned γ-axons and uncleared axonal debris as it is the case for the orion¹ MBs (n > 20). drpr^Δ5 MBs showed an intermediate phenotype: 85% of the MBs appeared wild-type, while 15% exhibited a mutant phenotype with at least some uncleared axonal debris (n > 20). A more detailed quantitation of unpruned axon and axon debris present in different genetic backgrounds can be found in our previous publication (Boulanger et al., 2021). (F–K) γ-neurons of 7-day adult flies were labeled with an anti-Dlp antibody (red). Unlike the previous labeling, this antibody labeled only the γ-neurons, making the unpruned axons and uncleared debris easily identifiable. With this labeling, 72% of drpr^Δ5 brains appeared wild-type, and 28% exhibited a mutant phenotype with at least unpruned axonal debris. Nimc1¹; eater¹ brains were correctly pruned. n > 20 MBs for each condition. (L) Proteins were extracted from 10 whole pupae at 6 h APF for each condition, and Drpr expression was analyzed through immunoblotting. Note the complete absence of Drpr expression under the drpr^indel3 condition compared to drpr^Δ5. Scale bars represent 40 μm. All images are z-stacked confocal images. Immunostainings were replicated at least three times. Genotypes are listed in the complementary list of fly strains.

Figure 2.

A. y w^67c23 sn³ orion¹ FRT19A/Y; UAS-mCD8GFP 201Y-GAL4/+; UAS-orionB-myc/+

B. y w^67c23 sn³ orion¹ FRT19A/Y; UAS-mCD8GFP 201Y-GAL4/+; UAS-orion-CD2-myc/+

Figure 2

Figure 2. Orion tethered to the axon membrane recruits Drpr at the MBs. (A,B) Third-instar larval MBs were visualized using the expression of 201Y-GAL4-driven UAS-mCD8-GFP (green). UAS-Orion-myc (A′) and UAS-Orion-CD2-myc (B′) were visualized with an anti-myc antibody (blue), and Drpr (A″, B″) was labeled with an anti-Drpr antibody (red). Note the complete absence of Drpr staining inside the MB in controls (A″) compared to the high amount of Drpr in the γ-lobe when Orion-CD2 is expressed in MBs and presented at the axonal membrane. (C) Quantitation of the Drpr area inside the MB γ-lobes. Values were normalized with the MB’s area and given as a ratio of “Drpr area inside the MB/MB area.” n values are indicated in the parenthesis and represent the number of MBs visualized. Error bars represent mean ± S.E.M. ****P < 0.0001 (Mann–Whitney U test). Immunostainings were replicated three times. Scale bars represent 10 μm. Images are single-slice confocal images, but the entire stack was analyzed. Genotypes are listed in the supplementary list of fly strains.

Figure 3.

A. y w^67c23/Y; UAS-mCD8GFP 201Y-GAL4/CyO or y w^67c23/Y; UAS-mCD8GFP 201Y-GAL4/UAS-mCD8GFP 201Y-GAL4

B. y w^67c23/y w^67c23; UAS-mCD8GFP 201Y-GAL4/+; UAS-orion-CD2, UAS > y⁺>mGFP/+ or y w^67c23/Y; UAS-mCD8GFP 201Y-GAL4/+; UAS-orion-CD2, UAS > y⁺>mGFP/+

C. y w^67c23/y w^67c23; UAS-mCD8GFP 201Y-GAL4/UAS-drpr; UAS-orion-CD2/+ or y w^67c23/Y; UAS-mCD8GFP 201Y-GAL4/UAS-drpr; UAS-orion-CD2/+

D. y w^67c23/y w^67c23; UAS-mCD8GFP 201Y-GAL4/UAS-drpr or y w^67c23/Y; UAS-mCD8GFP 201Y-GAL4/UAS-drpr

Figure 3

Figure 3. Drpr titrates membrane-tethered Orion in MBs. (A–F) γ-neurons of pupae at 6 h APF were visualized using the expression of 201Y-GAL4-driven UAS-mCD8-GFP (green). Compared to controls (A) and to drpr^indel3 (B), the expression of a membrane-tethered Orion-CD2 (along with a neutral UAS > y⁺> mGFP) in the MBs induces an earlier pruning and a characteristic ''headless'' phenotype (C). This headless phenotype is rescued both by drpr^indel3 (D) and by overexpression of Drpr in the MBs (E), suggesting an interaction between the two proteins. An overexpression of Drpr alone in the MBs does not induce any phenotype (F). (G,H) Models of interactions between Drpr and Orion-CD2 (before endogenous Orion secretion). When Orion-CD2 is expressed in the MBs, it interacts with astrocytic Drpr and induces a ''headless'' phenotype at 6 h APF (G). Overexpression of Drpr in the MBs leads to Orion-CD2 titration and prevents its interaction with endogenous astrocytic Drpr, resulting in the rescue of the pruning phenotype (H). (I) Quantitation of the number of “preserved” and “headless” dorsal γ-lobes in MBs at 6 h APF for each condition. n values are indicated in the parenthesis and correspond to the number of MBs. Experiments were replicated three times. ****P < 0.0001 (Chi-squared test). Scale bars represent 20 μm. Images are z-stacked confocal images. Genotypes are listed in the complementary list of fly strains. Figures (G,H) were created with BioRender.com.

Figure 4.

A. y w^67c23 sn3 FRT19A/y w^67c23; +; repo-GAL4 UAS-mCD8-GFP/+ or y w^67c23 sn3 FRT19A/Y; +; repo-GAL4 UAS-mCD8-GFP/+

B. y w^67c23/y w^67c23; +; repo-GAL4/UAS-orion-CD2 UAS-HO1 or y w^67c23/Y; +; repo-GAL4/UAS-orion-CD2 UAS-HO1

C. y w^67c23/y w^67c23; UAS-drpr/+; repo-GAL4/UAS-orion-CD2 or y w^67c23/Y; UAS-drpr/+; repo-GAL4/UAS-orion-CD2

D. w^67c23 orion^ΔC/Y

E. y w^67c23/y w^67c23; +; drpr^indel3/drpr^indel3 or y w^67c23/Y; +; drpr^indel3/drpr^indel3

F. y w^67c23/y w^67c23; UAS-drpr/+; repo-GAL4/+ or y w^67c23/Y; UAS-drpr/+; repo-GAL4/+

Figure 4

Figure 4. Membrane-tethered Orion titrates Drpr in astrocytes. (A–F) Dorsal γ-lobes of pupae at 24 h APF were visualized with an anti-Dlp antibody (red). At this developmental stage, some debris remained but axons were barely visible in controls (A). The glial expression of Orion-CD2 driven by repo-GAL4 (along with a neutral UAS-HO1) induces clear MB pruning defects with many unpruned axons and a thicker dorsal lobe (B). This pruning phenotype is rescued by the overexpression of Drpr in glia (C), indicating an interaction between Drpr and Orion-CD2. orion^ΔC (D) and drpr^indel3 (E) pupae both show a strong pruning phenotype, and overexpression of Drpr alone in glia does not induce a pruning phenotype (F). (G–I) Models of Drpr and Orion-CD2 interactions in pupae leading to the phenotypes described above. In controls (G), MB Orion and astrocytic Drpr interact, with normal pruning. When a membrane Orion-CD2 is expressed in astrocytes, its titration of Drpr prevents endogenous Orion binding, with visible pruning defects (H). When Drpr is overexpressed in glia along with Orion-CD2, there is a sufficient level of Drpr to interact with both Orion-CD2 and endogenous Orion, and the pruning defects are rescued (I). (J,K) Quantitation of the dorsal γ-lobe area at 24 h APF for each condition. n values are indicated in the parenthesis and represent the number of MBs visualized. Error bars represent mean ± S.E.M. ****P < 0.0001 (Mann–Whitney U-test). ns, non-significant. Experiments were replicated three times. Scale bars represent 20 μm. Images are z-stacked confocal images. Genotypes are listed in the complementary list of fly strains.

Results and discussion

Our laboratory published that Drpr was not, or at least not the sole, Orion receptor principally based on the different penetrance of the MB-pruning phenotype in orion^null (either orion¹ and orion^ΔC) and drpr^Δ5 (Boulanger et al., 2021). We showed here that drpr^Δ5 is not a null allele contrarily to drpr^indel3 (Figure 1). The MB-pruning phenotype of drpr^indel3 was very similar, if not identical, to that of orion¹ with 100% penetrance of the phenotype (n = 36 and n > 20 MBs, respectively), although most of the drpr^Δ5 MBs appeared wild-type, with only a minority of MBs showing unclear axonal debris and unpruned axons, as observed with UAS-mGFP under the control of 201Y-GAL4 (Figures 1A–E). We confirm these results by labeling the MBs with an anti-Dlp antibody, which, in adult, particularly labels the MB γ-neurons (Figures 1F–J). Drpr belongs to the Nimrod family of the phagocytic receptor together with NimC1 and Eater (Melcarne et al., 2019). NimC1 and eater double null mutant flies are deficient in the phagocytosis of all types of bacteria, suggesting that they are the two main phagocytic receptors for bacteria in Drosophila (Melcarne et al., 2019). Nevertheless, NimC1 and eater double null mutant flies had no effect on MB remodeling (Figure 1K). This may indicate that phagocytosis of neuronal debris after remodeling requires Drpr as a specialized signaling pathway but does not require the main receptors involved in microbe engulfment. Finally, we showed, through Western blotting, that although drpr^indel3 pupae did not produce any Drpr protein, some Drpr proteins were still present in drpr^Δ5 pupae, confirming the null allele status of drpr^indel3 (Figure 1L). These results are in accordance with drpr^Δ5 being a mutation affecting strongly, but not completely, the transcription of the drpr mRNA (Freeman et al., 2003). Therefore, in rare cases when a Drpr protein is produced, in drpr^Δ5 flies, it is a normal-sized protein. Contrarily, drpr^indel3 is a CRISPR mutation affecting the coding sequence, leading to a protein null (Sapar et al., 2018). It is expected that in an exclusive relationship between a ligand and its receptor for a particular process, the null mutant phenotype of each gene has a similar, if not identical, phenotype. This result is a strong indication that the glial phagocytic receptor Drpr functions as a receptor for the neuron-secreted Orion ligand during the MB remodeling process.

Orion is a signal peptide-bearing protein without any transmembrane domain. Therefore, Orion could move in the extracellular space (Boulanger et al., 2021). We wondered if expression of Orion that is permanently tethered to the plasma membrane of otherwise wild-type MB axons could alter Orion function and produce a gain-of-function phenotype. We examined L3 larvae, a stage when the remodeling process has normally not begun, and found that although expression of a wild-type UAS-orion transgene in the MBs showed no glial phenotype, expression of UAS-orion-CD2 dramatically recruited glia inside γ-axon bundles, as monitored by the presence of the Drpr receptor, which serves as a glial marker (Figure 2). We assessed that similar expression levels of Orion-Myc and Orion-CD2-Myc were observed at the tip of the larval dorsal γ-lobes (10604±561 and 11114±842, respectively, n = 25 measures on 5 MBs for each condition, p = 0.84, Mann–Whitney U test). In the UAS-orion-CD2 transgene, Orion is located on the extracellular side of the CD2 transmembrane domain and could potentially interact with the glial receptor Drpr. Why is there glia infiltration, at the L3 stage, when the UAS-orion-CD2 transgene, but not the wild-type UAS-orion transgene, is used? We can propose two non-exclusive hypotheses. One is that Orion-CD2, contrarily to Orion, is not secreted and therefore is immediately available for the potential protein–protein interaction. Another hypothesis could be a similar model for the MBs and for the C4da neuron dendrite pruning (Ji et al., 2023). The CD2 transmembrane domain contained in Orion-CD2 could mimic an extracellularly exposed molecule through which Orion could bridge Drpr. This molecule could be a glycosaminoglycan (GAG) since the GAG binding is necessary for Orion function (Boulanger et al., 2021) or PS as in the case of the C4da neurons. In L3 larvae, these molecules may not be present, or present but not yet functional. The artificial binding of Orion-CD2 to the γ-axon plasma membrane could circumvent the necessity of Orion binding to GAGs or PS, allowing a premature and likely more stable direct interaction with Drpr.

We then asked whether the gain-of-function phenotype caused by the expression of the UAS-orion-CD2 transgene in L3 (i.e., abnormal early attraction of glia on the MB) could produce a morphological phenotype later in development. We examined 6 h after puparium formation (APF) and found that contrarily to the wild-type situation, when the UAS-orion-CD2 transgene was expressed in MBs, the extremities of the lobes were missing. This phenotype is particularly evident in the dorsal lobe and was termed the “headless” phenotype (Figure 3) (Figures 3A–C). We reasoned that if this “headless” phenotype resulted from an interaction between neuronal Orion-CD2 and glial Drpr, it should be rescued in a drpr^null genetic background. Noteworthy, we observed a complete rescue of the Orion-CD2-induced headless phenotype in drpr^indel3 pupae at 6 h APF (Figure 3D). In addition, we hypothesized that ectopic expression of Drpr in MB axons, where it is not normally expressed, might also rescue the phenotype. Interestingly, we found a clear rescue of the “headless” phenotype under these conditions (Figure 3E). Notably, the lack of Drpr expression (in drpr^indel3 individuals) or the ectopic expression of Drpr alone in MBs did not produce an MB phenotype (Figures 3E,F). These results suggest that ectopic expression of Drpr in the MB neurons titrates Orion-CD2, thus preventing it from an early abnormal interaction with endogenous glial Drpr (Figures 3G–I ). The endogenous glial Drpr receptor is then available to interact normally with endogenous secreted Orion.

We finally asked whether Orion-CD2 could titrate endogenous glial Drpr. To address this, we ectopically expressed Orion-CD2 in glia and examined MB pruning at 24 h APF using an anti-Dlp antibody. Indeed, expression of Orion-CD2 in glia blocked the pruning process compared to the wild-type situation (Figures 4A,B). In addition, the pruning phenotype caused by ectopic expression of Orion-CD2 in glia was rescued when Drpr was simultaneously overexpressed in glia (Figure 4C). These phenotypes suggest that ectopic expression of Orion-CD2 in glia titrates endogenous glial Drpr, thereby preventing it from interacting with endogenous neuron-secreted Orion (Figures 4G,H). In addition, when Drpr is overexpressed in glia together with Orion-CD2, it titrates Orion-CD2, allowing the normal interaction between endogenous glial Drpr and endogenous neuron-secreted Orion (Figures 4D-F,I) and leading consequently to normal pruning.

The requirement of the presence of the Drpr protein to allow the Orion-CD2-induced headless phenotype and the titrating results of Drpr on Orion-CD2 and conversely of Orion-CD2 on Drpr associated to the similar, if not identical, mutant phenotype of both null alleles of drpr and orion strongly support the conclusion that the neuron-secreted chemokine-like Orion ligand interacts with the glial phagocytic receptor Drpr during MB remodeling in Drosophila.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The manuscript presents research on animals that do not require ethical approval for their study.

Author contributions

CP: Formal analysis, Investigation, Methodology, Visualization, Writing – original draft. AB: Conceptualization, Funding acquisition, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review and editing. J-MD: Conceptualization, Funding acquisition, Supervision, Writing – original draft, Writing – review and editing.

Funding

The author(s) declared that financial support was received for this work and/or its publication. CP was supported by grants from the Agence Nationale de la Recherche (ANR-21-CE16-0033-ORIO). Work in the laboratory of J-MD was supported by the Centre National de la Recherche Scientifique (CNRS) and the Agence Nationale de la Recherche (ANR-21-CE16-0033-ORIO to J-MD and ANR-24-CE16-5161-ExOrion to AB).

Acknowledgements

The authors thank Mark Freeman (Vollum Institute, Portland), Chun Han (Cornell University), Bruno Lemaitre (EPFL, Lausanne), and Reinhard Stocker (Fribourg University) for Drosophila stocks used in this study. The authors thank the Bloomington Drosophila Stock Center (Indiana University), the BioCampus RAM-Drosophila facility, and the BioCampus imaging facility MRI (Montpellier, France). The authors also thank BestGene and GENEWIZ for transgene service and DNA sequencing, respectively. The 1D4 anti-Fasciclin II hybridoma, the 13G8 anti-Dlp, and the 8A1 anti-Drpr monoclonal antibodies were obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at the Department of Biology, The University of Iowa, Iowa City, IA 52242. Figures 3G, H, 4G-I were created with BioRender.com.

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Boulanger, A., and Dura, J. M. (2015). Nuclear receptors and drosophila neuronal remodeling. Biochim. Biophys. Acta 1849, 187–195. doi:10.1016/j.bbagrm.2014.05.024

PubMed Abstract | CrossRef Full Text | Google Scholar

Boulanger, A., and Dura, J. M. (2022). Neuron-glia crosstalk in neuronal remodeling and degeneration: neuronal signals inducing glial cell phagocytic transformation in drosophila. Bioessays 44, e2100254. doi:10.1002/bies.202100254

PubMed Abstract | CrossRef Full Text | Google Scholar

Boulanger, A., Clouet-Redt, C., Farge, M., Flandre, A., Guignard, T., Fernando, C., et al. (2011). ftz-f1 and Hr39 opposing roles on EcR expression during drosophila mushroom body neuron remodeling. Nat. Neurosci. 14, 37–44. doi:10.1038/nn.2700

PubMed Abstract | CrossRef Full Text | Google Scholar

Boulanger, A., Thinat, C., Zuchner, S., Fradkin, L. G., Lortat-Jacob, H., and Dura, J. M. (2021). Axonal chemokine-like Orion induces astrocyte infiltration and engulfment during mushroom body neuronal remodeling. Nat. Commun. 12, 1849. doi:10.1038/s41467-021-22054-x

PubMed Abstract | CrossRef Full Text | Google Scholar

Cardozo, P. L., de Lima, I. B. Q., Maciel, E. M. A., Silva, N. C., Dobransky, T., and Ribeiro, F. M. (2019). Synaptic elimination in neurological disorders. Curr. Neuropharmacol. 17, 1071–1095. doi:10.2174/1570159X17666190603170511

PubMed Abstract | CrossRef Full Text | Google Scholar

Courchesne, E., Pierce, K., Schumann, C. M., Redcay, E., Buckwalter, J. A., Kennedy, D. P., et al. (2007). Mapping early brain development in autism. Neuron 56, 399–413. doi:10.1016/j.neuron.2007.10.016

PubMed Abstract | CrossRef Full Text | Google Scholar

Freeman, M. R., Delrow, J., Kim, J., Johnson, E., and Doe, C. Q. (2003). Unwrapping glial biology: gcm target genes regulating glial development, diversification, and function. Neuron 38, 567–580. doi:10.1016/s0896-6273(03)00289-7

PubMed Abstract | CrossRef Full Text | Google Scholar

Ji, H., Wang, B., Shen, Y., Labib, D., Lei, J., Chen, X., et al. (2023). The drosophila chemokine-like Orion bridges phosphatidylserine and draper in phagocytosis of neurons. Proc. Natl. Acad. Sci. U. S. A. 120, e2303392120. doi:10.1073/pnas.2303392120

PubMed Abstract | CrossRef Full Text | Google Scholar

Luo, L., and O'Leary, D. D. (2005). Axon retraction and degeneration in development and disease. Annu. Rev. Neurosci. 28, 127–156. doi:10.1146/annurev.neuro.28.061604.135632

PubMed Abstract | CrossRef Full Text | Google Scholar

Melcarne, C., Lemaitre, B., and Kurant, E. (2019). Phagocytosis in Drosophila: from molecules and cellular machinery to physiology. Insect Biochem. Mol. Biol. 109, 1–12. doi:10.1016/j.ibmb.2019.04.002

PubMed Abstract | CrossRef Full Text | Google Scholar

Neniskyte, U., and Gross, C. T. (2017). Errant gardeners: glial-cell-dependent synaptic pruning and neurodevelopmental disorders. Nat. Rev. Neurosci. 18, 658–670. doi:10.1038/nrn.2017.110

PubMed Abstract | CrossRef Full Text | Google Scholar

Neukomm, L. J., and Freeman, M. R. (2014). Diverse cellular and molecular modes of axon degeneration. Trends Cell. Biol. 24, 515–523. doi:10.1016/j.tcb.2014.04.003

PubMed Abstract | CrossRef Full Text | Google Scholar

Perron, C., Carme, P., Rosell, A. L., Minnaert, E., Ruiz-Demoulin, S., Szczkowski, H., et al. (2023). Chemokine-like Orion is involved in the transformation of glial cells into phagocytes in different developmental neuronal remodeling paradigms. Development 150, dev201633. doi:10.1242/dev.201633

PubMed Abstract | CrossRef Full Text | Google Scholar

Redt-Clouet, C., Trannoy, S., Boulanger, A., Tokmatcheva, E., Savvateeva-Popova, E., Parmentier, M. L., et al. (2012). Mushroom body neuronal remodelling is necessary for short-term but not for long-term courtship memory in Drosophila. Eur. J. Neurosci. 35, 1684–1691. doi:10.1111/j.1460-9568.2012.08103.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Sapar, M. L., Ji, H., Wang, B., Poe, A. R., Dubey, K., Ren, X., et al. (2018). Phosphatidylserine externalization results from and causes neurite degeneration in drosophila. Cell. Rep. 24, 2273–2286. doi:10.1016/j.celrep.2018.07.095

PubMed Abstract | CrossRef Full Text | Google Scholar

Schuldiner, O., and Yaron, A. (2015). Mechanisms of developmental neurite pruning. Cell. Mol. Life Sci. 72, 101–119. doi:10.1007/s00018-014-1729-6

PubMed Abstract | CrossRef Full Text | Google Scholar

Tasdemir-Yilmaz, O. E., and Freeman, M. R. (2014). Astrocytes engage unique molecular programs to engulf pruned neuronal debris from distinct subsets of neurons. Genes. Dev. 28, 20–33. doi:10.1101/gad.229518.113

PubMed Abstract | CrossRef Full Text | Google Scholar

Trannoy, S., Redt-Clouet, C., Dura, J. M., and Preat, T. (2011). Parallel processing of appetitive short- and long-term memories in Drosophila. Curr. Biol. 21, 1647–1653. doi:10.1016/j.cub.2011.08.032

PubMed Abstract | CrossRef Full Text | Google Scholar

Yu, F., and Schuldiner, O. (2014). Axon and dendrite pruning in Drosophila. Curr. Opin. Neurobiol. 27, 192–198. doi:10.1016/j.conb.2014.04.005

PubMed Abstract | CrossRef Full Text | Google Scholar